Last reviewed · How we verify

NCT04908891

A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and Interrelatedness

Completed NA Last updated 12 July 2024
What this trial tests

NA trial testing Clinical Scapular protocol (ClinScaP) in Multiple Sclerosis in 78 participants. Completed in 30 August 2022.

Timeline
12 December 2018
Primary endpoint
30 August 2021
30 August 2022

Quick facts

Lead sponsorHasselt University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment78
Start date12 December 2018
Primary completion30 August 2021
Estimated completion30 August 2022
Sites4 locations across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Multiple Sclerosis or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aimed to provide insights in the coordination between trunk, shoulder and upper limb while reaching. Two main phases are present in this study: In phase A: the psychometric properties of two tests: Clinical Scapular protocol (ClinScaP) in PwMS (Persons with Multiple Sclerosis) and healthy controls. 1. To investigate the test-retest reliability of the Clinical Scapular Protocol (ClinScaP) and the Reaching Performance Scale (RPS) in PwMS 2. To investigate the discriminative of the ClinScaP between PwMS and healthy controls 3. To investigate the discriminative of the RPS between PwMS and healthy controls 4. To investigate the concurrent validity of ClinScaP and RPS in PwMS, compared with upper limb dysfunction measurements. In phase B: 5. To investigate the prevalence of trunk, scapula and upper limb impairments in PwMS and stroke patients. 6. To investigate the interaction between trunk, scapula and upper limb impairments in PwMS and stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04908891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing